Skip to main content
. 2017 Feb 1;8(13):20719–20728. doi: 10.18632/oncotarget.14988

Figure 6. Diagnostic performance of the urinary four-biomarker panel for the diagnosis of early-stage BC.

Figure 6

ROC curves of the urinary four-biomarker panel for NMI BCs vs. HCs in the (A) discovery set and (B) external validation set. ROC curves of the urinary four-biomarker panel for LG BCs vs. HCs in the (C) discovery set and (D) external validation set.